SanBio's earnings have been declining at an average annual rate of -0.4%, while the Biotechs industry saw earnings growing at 29.1% annually.
Key information
-0.39%
Earnings growth rate
6.96%
EPS growth rate
Biotechs Industry Growth
17.04%
Revenue growth rate
n/a
Return on equity
-28.24%
Net Margin
n/a
Last Earnings Update
31 Jan 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How SanBio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:SNBI.F Revenue, expenses and earnings (JPY Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Jan 26
0
-3,842
1,116
2,678
31 Oct 25
0
-3,444
1,095
2,612
31 Jul 25
0
-3,570
1,154
2,679
30 Apr 25
0
-4,270
1,163
2,694
31 Jan 25
0
-2,882
1,159
2,357
31 Oct 24
0
-2,914
1,228
2,069
31 Jul 24
0
-2,166
1,265
1,761
30 Apr 24
0
-2,162
1,556
2,188
31 Jan 24
0
-2,644
1,690
2,849
31 Oct 23
0
-5,684
1,636
3,584
31 Jul 23
0
-5,192
1,752
4,610
30 Apr 23
0
-5,870
1,720
5,796
31 Jan 23
0
-5,559
1,781
6,118
31 Oct 22
0
-3,320
1,895
6,390
31 Jul 22
0
-4,697
1,865
6,324
30 Apr 22
0
-4,132
1,725
5,199
31 Jan 22
0
-4,677
1,665
4,955
31 Oct 21
0
-1,659
1,709
4,643
31 Jul 21
0
-2,312
1,759
4,524
30 Apr 21
0
-2,738
1,759
4,340
31 Jan 21
0
-3,385
1,730
4,071
31 Oct 20
23
-6,718
1,629
4,439
31 Jul 20
20
-6,316
1,579
4,112
30 Apr 20
258
-5,928
1,648
4,089
31 Jan 20
447
-5,157
1,606
4,327
31 Oct 19
597
-4,651
1,313
4,086
31 Jul 19
753
-3,927
1,110
4,065
30 Apr 19
772
-2,819
826
3,844
31 Jan 19
741
-2,920
673
3,721
31 Oct 18
687
-2,331
722
3,654
31 Jul 18
656
-2,705
676
3,824
30 Apr 18
525
-3,680
686
4,199
31 Jan 18
490
-3,940
712
4,156
31 Oct 17
562
-3,302
791
3,641
31 Jul 17
514
-2,966
854
3,115
30 Apr 17
447
-2,655
840
2,621
31 Jan 17
949
-1,835
806
2,058
31 Oct 16
833
-2,209
722
1,884
31 Jul 16
1,447
-1,693
673
1,954
30 Apr 16
1,515
-1,156
625
1,856
31 Jan 16
1,174
-988
604
1,695
31 Oct 15
1,208
-647
548
1,390
Quality Earnings: SNBI.F is currently unprofitable.
Growing Profit Margin: SNBI.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SNBI.F is unprofitable, and losses have increased over the past 5 years at a rate of 0.4% per year.
Accelerating Growth: Unable to compare SNBI.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SNBI.F is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (40.2%).
Return on Equity
High ROE: SNBI.F has a negative Return on Equity (-28.24%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/03/29 17:09
End of Day Share Price
2025/12/30 00:00
Earnings
2026/01/31
Annual Earnings
2026/01/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SanBio Company Limited is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.